4//SEC Filing
Morgan Leigh 4
Accession 0000899243-22-025817
CIK 0001815442other
Filed
Jul 7, 8:00 PM ET
Accepted
Jul 8, 4:10 PM ET
Size
5.3 KB
Accession
0000899243-22-025817
Insider Transaction Report
Form 4
Morgan Leigh
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-06+24,000→ 24,000 totalExercise: $23.59Exp: 2032-07-05→ Common Stock (24,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in thirty-six (36) equal monthly installments over three (3) years beginning on July 6, 2022..
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001935887
Filing Metadata
- Form type
- 4
- Filed
- Jul 7, 8:00 PM ET
- Accepted
- Jul 8, 4:10 PM ET
- Size
- 5.3 KB